NCT05327673View on ClinicalTrials.gov

Impact of the Use of Allogeneic Hematopoietic Stem Cell Transplantation in Reunion Island Patients: Quality of Life, Determinants of Choices and Financial Repercussions

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2022

Primary Completion Date

January 31, 2027

Study Completion Date

March 31, 2027

Conditions
Allogeneic Hematopoietic Stem Cell Transplantation
Interventions
OTHER

questionnaire

"* quality of life score: FACT-BMT~* decisional conflict scale~* Discreet Choice Experiment questionnaire"

Trial Locations (1)

97448

CHU de la Réunion, Saint-Pierre

All Listed Sponsors
collaborator

Institut Paoli-Calmettes

OTHER

lead

Centre Hospitalier Universitaire de la Réunion

OTHER

NCT05327673 - Impact of the Use of Allogeneic Hematopoietic Stem Cell Transplantation in Reunion Island Patients: Quality of Life, Determinants of Choices and Financial Repercussions | Biotech Hunter | Biotech Hunter